Frontotemporal lobar degeneration (FTLD) is distinct from Alzheimer's disease and other types of dementia due to its specific impact on the frontal and temporal lobes of the brain. Unlike Alzheimer's, which primarily affects memory, FTLD initially manifests with changes in personality, behavior, and language skills. These alterations often precede significant memory loss. FTLD encompasses several subtypes, each affecting different aspects of cognition and behavior. Unlike Alzheimer's, which is marked by the accumulation of amyloid plaques and tau protein tangles, FTLD is associated with abnormal deposits of proteins such as tau, TDP-43, or FUS. Understanding these distinctions is crucial for accurate diagnosis and treatment, as FTLD requires tailored management approaches distinct from those used for Alzheimer's disease and other forms of dementia.
Title : Make a difference
Jacqueline Tuppen, Dementia UK, United Kingdom
Title : Imaging brain clearance in Alzheimer’s disease
Jun Hua, Johns Hopkins University , United States
Title : Association between APOE allele prevalence and Alzheimer's disease risk in Southwestern Uganda
Frank Balikoowa, African Research Center for Ageing & Dementia, Uganda
Title : Healthcare professionals in Somaliland had low levels of knowledge and attitudes towards dementia care: A pilot survey
Mohamed Abdilahi Duale, Frantz Fanon University, Somalia
Title : Association between depressive symptoms and cognitive impairment severity in a real-world memory clinic cohort
Yun Ju Hsieh, Taipei City Hospital, Taiwan
Title : Neuromodulation of scalp electroacupuncture in the treatment of autism spectrum disorder
Zhenhuan Liu, Nanhai Maternity and Children Hospital Affiliated to Guangzhou University of Chinese Medicine, China